News on haematological malignancies
Joining forces with nature for new cancer therapies
Natural compounds often have promising therapeutic potential but their use to treat diseases is hampered…
Browsing: Haematology
Immunity boosting treatment enhances CAR-T cell therapy for blood cancers
Advances in cellular immunotherapy that spur genetically modified T cells to attack cancer cells have…
Researchers discover genes that predict good response to blood cancer therapy
Mount Sinai researchers have for the first time identified genes that predict a good response…
EHA 2022: A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma
Chimeric antigen receptor (CAR) T cell therapy is a form of immunotherapy in which T…
EHA 2022: Improved progression-free survival is achievable using targeted therapy combinations with venetoclax in fit patients with treatment-naïve chronic lymphocytic leukaemia
Chemoimmunotherapy (CIT) is still standard treatment for patients with chronic lymphocytic leukaemia (CLL), particularly when…
EHA 2022: Quizartinib improves overall survival in adults with FLT3-ITD+ acute myeloid leukaemia
Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults, and approximately 25%…
EHA 2022: Decitabine shows similar survival and fewer adverse events compared to standard chemo in geriatric AML
Acute myeloid leukaemia (AML) predominantly occurs in older adults over 65 years, who exhibit a…
EHA 2022: Ibrutinib combination with bendamustine-rituximab and rituximab maintenance as a first-line treatment for older patients with mantle cell lymphoma significantly improves PFS
Mantle cell lymphoma (MCL) is an aggressive type of non-Hodgkin lymphoma that develops from B…
EHA 2022: Adding targeted therapy to chemoimmunotherapy offers long-term benefits for patients with IGHV-mutated CLL
Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) is effective in treating patients with chronic lymphocytic leukaemia (CLL),…
ALLG May 2022 Scientific Meeting Review
By ALLG Opportunities for collaboration, both virtual and face-to-face, for peer review and networking are…